What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Virus
- Cancer
Douglas T. Dieterich mainly focuses on Internal medicine, Immunology, Hepatitis C virus, Ribavirin and Hepatitis C.
As part of the same scientific family, Douglas T. Dieterich usually focuses on Internal medicine, concentrating on Gastroenterology and intersecting with Liver biopsy.
His Immunology research includes elements of Clinical trial and Risk factor.
Douglas T. Dieterich studies Hepatitis C virus, namely Sofosbuvir.
Ribavirin is a subfield of Virology that Douglas T. Dieterich investigates.
His Hepatitis C study combines topics from a wide range of disciplines, such as Pharmacotherapy, Adverse effect, Acquired immunodeficiency syndrome and Viral load.
His most cited work include:
- Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. (1123 citations)
- Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel. (400 citations)
- Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study (367 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Hepatitis C virus, Virology, Ribavirin and Hepatitis C.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Viral load, Immunology and Sofosbuvir.
As part of one scientific family, Douglas T. Dieterich deals mainly with the area of Hepatitis C virus, narrowing it down to issues related to the Cirrhosis, and often Fibrosis.
His work in the fields of Virology, such as Virus, Faldaprevir, Hepatitis B virus and Interferon, intersects with other areas such as In patient.
His Ribavirin research incorporates themes from Regimen, Adverse effect and Alpha interferon.
His Hepatitis C research is multidisciplinary, incorporating elements of Direct acting, Surgery, Pharmacology and Hepatitis.
He most often published in these fields:
- Internal medicine (47.37%)
- Hepatitis C virus (32.63%)
- Virology (30.53%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (47.37%)
- Hepatitis C (29.47%)
- Hepatitis C virus (32.63%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Hepatitis C, Hepatitis C virus, Virology and Gastroenterology.
His Internal medicine study incorporates themes from Surgery, Oncology and Ribavirin, Genotype, Sofosbuvir.
His research on Hepatitis C also deals with topics like
- Liver disease that connect with fields like Immunology,
- Direct acting, which have a strong connection to Antiviral treatment.
His studies in Hepatitis C virus integrate themes in fields like Interquartile range, Viral load, Hepatocellular carcinoma, Prospective cohort study and Drug.
In general Virology study, his work on Telaprevir and Virus often relates to the realm of In patient, thereby connecting several areas of interest.
Douglas T. Dieterich has researched Gastroenterology in several fields, including Nonalcoholic fatty liver disease and Liver transplantation.
Between 2015 and 2021, his most popular works were:
- American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. (128 citations)
- Real-world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C: the Trio Health study (55 citations)
- Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real-world cohort study. (47 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
